BBOTVSCDT• 3 Months (Normalized)
BBOT vs CDT (BridgeBio Oncology Therapeutics Inc. vs CDT Equity Inc.)
Showing Closing Date Range from Jul 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.6
-60.09%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
CDT Performance $0.92
-99.17%
CDT Equity Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+39.08 pts
BBOT outperforming by 39.08 percentage points
BBOTCDT
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT CDT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BBOT Price | BBOT Gain (%) | CDT Price | CDT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $3.60 | -60.09% | $0.92 | -99.17% | +39.08% |
| Oct 02, 2026 | $3.89 | -56.87% | $0.99 | -99.10% | +42.23% |
| Oct 01, 2026 | $- | $1.25 | -98.87% | - | |
| Sep 30, 2026 | $4.10 | -54.55% | $1.36 | -98.77% | +44.22% |
| Sep 29, 2026 | $3.92 | -56.54% | $1.45 | -98.69% | +42.15% |
| Sep 28, 2026 | $3.81 | -57.76% | $1.90 | -98.28% | +40.52% |
| Sep 25, 2026 | $3.95 | -56.21% | $2.00 | -98.19% | +41.98% |
| Sep 24, 2026 | $3.99 | -55.76% | $3.03 | -97.26% | +41.50% |
| Sep 23, 2026 | $4.16 | -53.88% | $3.38 | -96.95% | +43.07% |
| Sep 22, 2026 | $4.66 | -48.34% | $3.55 | -96.79% | +48.45% |
| Sep 21, 2026 | $4.66 | -48.34% | $3.85 | -96.52% | +48.18% |
| Sep 18, 2026 | $4.77 | -47.12% | $4.35 | -96.06% | +48.94% |
| Sep 17, 2026 | $4.89 | -45.79% | $4.75 | -95.70% | +49.91% |
| Sep 16, 2026 | $4.76 | -47.23% | $4.95 | -95.52% | +48.29% |
| Sep 15, 2026 | $4.88 | -45.90% | $5.08 | -95.41% | +49.51% |
Page 1 of 5